Cover reporter Shao Meng
On July 28, the cover reporter learned from the National Health and Health Commission that in order to further strengthen drug safety management and improve the level of rational drug use, the National Health and Health Commission, the National Center for The Food and Drug Administration jointly issued the “Notice on Further Strengthening Medication Safety Management and Improving the Level of Rational Medication” (the “Notice”), which requires reducing the risk of medication errors, actively responding to adverse drug reactions, and strengthening medication safety supervision.
Data map. Photo by Xinhua News Agency reporter Peng Ziyang
Establish a high-alert drug and confusing drug management system
< p> The “Notice” mentioned that the management of the use of key drugs should be strengthened. Medical institutions should establish a management system for high-alert drugs and easily confusing drugs, and store and set up warning signs for high-alert drugs and drugs with multiple specifications, appearances, and sounds that are confusing in their own institutions. Strengthen key monitoring of the use and management of rational drug use, antimicrobial drugs, anti-tumor drugs, proton pump inhibitors, glucocorticoids, drugs for narcotics, narcotics, and traditional Chinese medicine injections. Through blood drug concentration monitoring, genetic testing, etc., we can identify drug risks, formulate individualized drug regimens, optimize drug variety selection, and accurately determine drug doses.
The “Notice” requires medical institutions to strengthen drug safety management for the elderly, children, pregnant women and other special groups. Establish a medication management system for elderly patients, take hierarchical management measures for elderly patients with different risk levels, strengthen medication explanations and reminders, and avoid wrong medication. When selecting medicines for children (limited to medicines with clear indications for children and dosage for children in the drug insert), it is not limited by “one product, two regulations” and the total number of medicines, the scope of medicines can be increased, and precise medicines can be promoted. According to the characteristics of pregnant and lying-in women, it is necessary to strengthen the management of all aspects of rational drug use, focus on the use of drugs with caution in pregnant and lying-in women, and strive to achieve “the smallest effective dose, the shortest effective course of treatment, and the least toxic side effects”, and minimize the impact on pregnant women and fetuses.
Adverse drug reactions should be “reported if suspicious”
The “Notice” emphasizes that medical institutions should prepare drugs according to regulations Monitoring reports of adverse reactions, actively collect adverse drug reactions, and report relevant information to relevant departments in a timely manner in accordance with the principle of “reporting if suspicious”, so as to improve the quantity and quality of reports. Establish and save adverse drug reaction reports and monitoring files, and clear and withdraw from the drug supply catalog of the institution in accordance with laws and regulations for drugs with many adverse reactions and prominent safety hazards.
Medical institutions should earnestly analyze adverse drug reaction reports and monitoring data, put forward targeted improvement goals, and take effective measures to reduce and prevent the recurrence of adverse drug reactions. When a medical institution discovers a serious adverse drug reaction, it shall immediately suspend the use of the drug and actively treat the patient while reporting it as required. The pharmacy department immediately conducts drug traceability and quality assessment, investigates the cause, and makes observations and records; after the assessment, it is determined whether to continue to use or replace the drug.
Increase the weight of rational drug use indicators in the performance appraisal of public hospitals
The “Notice” also requires that medical institutions should strengthen the Standardized supervision and management of practice behaviors to ensure that prescriptions are issued rationally in accordance with the national formulary, clinical diagnosis and treatment guidelines, guidelines for clinical application of drugs, and clinical pathways. Regularly organize professional and technical personnel to comment on prescription medical orders according to a certain proportion, and incorporate the comment results into the performance assessment and annual assessment indicators of relevant departments and their staff.
At the same time, the health administrative departments at all levels (including the competent Chinese medicine departments) shall, in accordance with the adjustment and update of the relevant norms, guidelines and standards for clinical medication, timely do a good job in the regular assessment of physicians. Include the content of medication safety into the evaluation indicators for promoting the high-quality development of public hospitals, and increase the weight of indicators related to rational drug use in the performance assessment of public hospitals.
【If you have news clues, welcome to report to us. Once adopted, you will be paid a fee. Newsletter WeChat Follow: ihxdsb, Newsletter QQ: 3386405712]